Metraipolis › archive › dc_eef322df89a9

AKT2 Exon 3 Variants and Their Prevalence in Prostate Cancer Patients: Insights from a Jordanian Clinical Cohort — Europe PMC PMID:42196210

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42196210
DOI
10.3390/ijms27104228
License (as archived)
solo-consultazione
Archived
2026-11-02T12:46:53.047Z
SHA-256 of the archived text
62d27528cb851e4f11de1564860324dbceab655df6aa943e109f7dda5d4909e7
Stable URL of this page
https://metraipolis.com/documento/dc_eef322df89a9

How to cite

AKT2 Exon 3 Variants and Their Prevalence in Prostate Cancer Patients: Insights from a Jordanian Clinical Cohort — Europe PMC PMID:42196210 — Europe PMC (en), https://europepmc.org/article/MED/42196210 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eef322df89a9 (Metraipolis archive dc_eef322df89a9, sha256 62d27528cb851e4f11de1564860324dbceab655df6aa943e109f7dda5d4909e7)
BibTeX
@misc{dceef322df89a9,
  title = {AKT2 Exon 3 Variants and Their Prevalence in Prostate Cancer Patients: Insights from a Jordanian Clinical Cohort — Europe PMC PMID:42196210},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42196210},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eef322df89a9; sha256 62d27528cb851e4f11de1564860324dbceab655df6aa943e109f7dda5d4909e7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42196210. Agents can read the archived copy with the MCP tool read_document.